These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae. Ogawa W; Onishi M; Ni R; Tsuchiya T; Kuroda T Gene; 2012 May; 498(2):177-82. PubMed ID: 22391093 [TBL] [Abstract][Full Text] [Related]
30. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae. Tian Y; Zhang Q; Wen L; Chen J Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782 [TBL] [Abstract][Full Text] [Related]
31. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors. Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653 [TBL] [Abstract][Full Text] [Related]
32. Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB. Reading E; Ahdash Z; Fais C; Ricci V; Wang-Kan X; Grimsey E; Stone J; Malloci G; Lau AM; Findlay H; Konijnenberg A; Booth PJ; Ruggerone P; Vargiu AV; Piddock LJV; Politis A Nat Commun; 2020 Nov; 11(1):5565. PubMed ID: 33149158 [TBL] [Abstract][Full Text] [Related]
33. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae. Yuhan Y; Ziyun Y; Yongbo Z; Fuqiang L; Qinghua Z Rev Soc Bras Med Trop; 2016 Apr; 49(2):165-71. PubMed ID: 27192584 [TBL] [Abstract][Full Text] [Related]
34. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. Guglierame P; Pasca MR; De Rossi E; Buroni S; Arrigo P; Manina G; Riccardi G BMC Microbiol; 2006 Jul; 6():66. PubMed ID: 16857052 [TBL] [Abstract][Full Text] [Related]
35. Detection of acrA, acrB, aac(6')-Ib-cr, and qepA genes among clinical isolates of Escherichia coli and Klebsiella pneumoniae. Heidary M; Bahramian A; Hashemi A; Goudarzi M; Omrani VF; Eslami G; Goudarzi H Acta Microbiol Immunol Hung; 2017 Mar; 64(1):63-69. PubMed ID: 27936860 [TBL] [Abstract][Full Text] [Related]
36. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps. Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445 [TBL] [Abstract][Full Text] [Related]
37. AcrB: a mean, keen, drug efflux machine. Kobylka J; Kuth MS; Müller RT; Geertsma ER; Pos KM Ann N Y Acad Sci; 2020 Jan; 1459(1):38-68. PubMed ID: 31588569 [TBL] [Abstract][Full Text] [Related]
38. In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae. Bialek-Davenet S; Marcon E; Leflon-Guibout V; Lavigne JP; Bert F; Moreau R; Nicolas-Chanoine MH Antimicrob Agents Chemother; 2011 Jun; 55(6):2795-802. PubMed ID: 21464248 [TBL] [Abstract][Full Text] [Related]
39. Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli. Soparkar K; Kinana AD; Weeks JW; Morrison KD; Nikaido H; Misra R J Bacteriol; 2015 Oct; 197(20):3255-64. PubMed ID: 26240069 [TBL] [Abstract][Full Text] [Related]
40. Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae isolates. Park Y; Choi Q; Kwon GC; Koo SH J Clin Lab Anal; 2020 Dec; 34(12):e23506. PubMed ID: 32815626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]